Anti-ARL4D

Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
E-AB-52847.20 20 µl -

7 - 16 Werktage*

89,00 €
E-AB-52847.60 60 µl -

7 - 16 Werktage*

174,00 €
E-AB-52847.120 120 µl -

7 - 16 Werktage*

292,00 €
E-AB-52847.200 200 µl -

7 - 16 Werktage*

485,00 €
 
ADP-ribosylation factor 4D is a member of the ADP-ribosylation factor family of GTP-binding... mehr
Produktinformationen "Anti-ARL4D"
ADP-ribosylation factor 4D is a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL4D is closely similar to ARL4A and ARL4C and each has a nuclear localization signal and an unusually high guanine nucleotide exchange rate. This protein may play a role in membrane-associated intracellular trafficking. Mutations in this gene have been associated with Bardet-Biedl syndrome (BBS). Protein function: Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase- activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. Recruits CYTH1, CYTH2, CYTH3 and CYTH4 to the plasma membrane in GDP-bound form. [The UniProt Consortium]
Schlagworte: Anti-ARL4D, Anti-ARF4L, Anti-ADP-ribosylation factor-like protein 4D, Anti-ADP-ribosylation factor-like protein 4L, ARL4D Polyclonal Antibody
Hersteller: Elabscience
Hersteller-Nr: E-AB-52847

Eigenschaften

Anwendung: IHC, ELISA
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human, mouse
Immunogen: Fusion protein of human ARL4D

Handhabung & Sicherheit

Lagerung: -20°C
Versand: 4°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-ARL4D"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen